StockNews.com Initiates Coverage on Mannatech (NASDAQ:MTEX)

Research analysts at StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX) in a report issued on Sunday. The firm set a “buy” rating on the stock.

Mannatech Price Performance

Shares of NASDAQ:MTEX opened at $7.82 on Friday. The business has a fifty day moving average price of $7.74 and a 200-day moving average price of $7.54. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.17 and a quick ratio of 0.62. The company has a market capitalization of $14.70 million, a PE ratio of -12.41 and a beta of 1.17. Mannatech has a 1-year low of $6.75 and a 1-year high of $10.51.

Mannatech (NASDAQ:MTEX) last released its quarterly earnings data on Tuesday, August 13th. The company reported ($0.33) earnings per share for the quarter. The firm had revenue of $27.74 million for the quarter. Mannatech had a negative net margin of 0.97% and a negative return on equity of 11.87%.

Insider Activity at Mannatech

In other Mannatech news, Director Larry A. Jobe sold 16,288 shares of Mannatech stock in a transaction on Monday, September 9th. The stock was sold at an average price of $7.75, for a total value of $126,232.00. Following the completion of the sale, the director now owns 54,721 shares of the company’s stock, valued at approximately $424,087.75. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 41.50% of the stock is currently owned by insiders.

About Mannatech

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.